Premier Diversified Holdings Inc. Announces Cease Trade Order and Provides Update on the Proposed Acquisition of AJA Health and Wellness Ltd., Assured Diagnosis Inc., and AJA Therapeutics Inc. - Seite 2

AJA Health and ADI are diligently working on having audits completed on their financial statements. Following receipt of the audited financial statements, PDH intends to make an application to the TSX Venture Exchange for conditional approval of the Acquisition.

Contingent upon the RTO Transaction being completed, the Corporation intends to change its name to “AJA Health and Wellness Inc.”, or such other name as may be determined by the board of directors of the Corporation.

AJA Health and Wellness Ltd.

AJA Health is a privately owned Alberta-based Canadian telemedicine company that has developed GOeVisit, an innovative platform which provides virtual consultations 24/7 from coast to coast. GOeVisit is a fully integrated, secure and virtual based health platform to enable and support online, real‐time appointments via face-to-face technology or smart phone with a health practitioner at a fraction of the time of a traditional appointment. AJA Health’s medical team uses proven virtual practice guidelines to diagnose, treat and prescribe for over 450 episodic medical conditions via computer, tablet or smartphone. Aja Health also operates full-service travel clinics in Vancouver and Surrey, BC.

At the special meeting of shareholders of AJA Health, held on December 8, 2023, a special majority of shareholders of AJA Health approved a form of amalgamation agreement among PDH, AJA Health, and a newly formed Alberta Corporation ("Newco 1"), pursuant to which it is proposed that Newco 1 and AJA Health amalgamate to continue as a new corporation, which will be a wholly owned subsidiary of PDH under the name "AJA Health and Wellness Ltd.".

On September 26, 2023, AJA Health completed the first tranche of its previously announced private placement financing of Class A Common Shares (the "Shares") of AJA Health at a price of USD$0.15 per Share for gross proceeds of USD$160,000.05.

On December 6, 2023, AJA Health completed the second tranche of its private placement financing of the Shares at a price of USD$0.15 per Share for gross proceeds of USD$250,000.05.

AJA Health anticipates closing additional tranches of its private placement financing to raise an aggregate of CAD$2,500,000. There can be no assurances that AJA Health will elect to close additional tranches.

When a definitive agreement between PDH, AJA Health, and Newco 1 is executed, PDH will issue a subsequent press release containing the details of the definitive agreement and additional terms of the Acquisition.